United-Guardian Inc
NASDAQ:UG
Intrinsic Value
United-Guardian, Inc. develops and manufactures pharmaceuticals, cosmetic ingredients, personal and health care products and medical devices. [ Read More ]
The intrinsic value of one UG stock under the Base Case scenario is 7.578 USD. Compared to the current market price of 7.755 USD, United-Guardian Inc is Overvalued by 2%.
Valuation Backtest
United-Guardian Inc
Run backtest to discover the historical profit from buying and selling UG stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
United-Guardian Inc
Current Assets | 11.6m |
Cash & Short-Term Investments | 8.1m |
Receivables | 1.8m |
Other Current Assets | 1.8m |
Non-Current Assets | 550k |
PP&E | 560k |
Other Non-Current Assets | -10k |
Current Liabilities | 1.5m |
Accounts Payable | 170k |
Accrued Liabilities | 1.3m |
Other Current Liabilities | 10k |
Non-Current Liabilities | 50k |
Other Non-Current Liabilities | 50k |
Earnings Waterfall
United-Guardian Inc
Revenue
|
11m
USD
|
Cost of Revenue
|
-5.8m
USD
|
Gross Profit
|
5.3m
USD
|
Operating Expenses
|
-2.5m
USD
|
Operating Income
|
2.7m
USD
|
Other Expenses
|
-190k
USD
|
Net Income
|
2.5m
USD
|
Free Cash Flow Analysis
United-Guardian Inc
What is Free Cash Flow?
UG Profitability Score
Profitability Due Diligence
United-Guardian Inc's profitability score is 72/100. The higher the profitability score, the more profitable the company is.
Score
United-Guardian Inc's profitability score is 72/100. The higher the profitability score, the more profitable the company is.
UG Solvency Score
Solvency Due Diligence
United-Guardian Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
United-Guardian Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
UG Price Targets Summary
United-Guardian Inc
Ownership
UG Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
UG Price
United-Guardian Inc
Average Annual Return | -6.07% |
Standard Deviation of Annual Returns | 26.51% |
Max Drawdown | -76% |
Market Capitalization | 35.6m USD |
Shares Outstanding | 4 594 320 |
Percentage of Shares Shorted | 0.09% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
United-Guardian, Inc. develops and manufactures pharmaceuticals, cosmetic ingredients, personal and health care products and medical devices. The company is headquartered in Hauppauge, New York and currently employs 22 full-time employees. Its cosmetic ingredients include Lubrajel PF, Lubrajel Oil PF, Lubrajel II XD PF, Lubrajel Natural, Lubrajel Marine, Lubrajel II XD, Lubrasil II SB, B-122, Klensoft and Orchid Complex. Its medical lubricants include Lubrajel RR and RC, Lubrajel MG, Lubrajel LC and Lubrajel FA, and Lubrajel Fluid. Its pharmaceuticals products include Renacidin, which is a prescription drug product that is used to prevent and to dissolve calcifications in urethral catheters, and in the urinary bladder, and Clorpactin WCS90, which is an antimicrobial product used in urology to treat infections in the urinary bladder. Its industrial products consist of Deselex, which is a sequestering and chelating agent that is used as a replacement for phosphates in the manufacture of detergents, and Thoroclens, which is a chlorine-based industrial cleanser.
Contact
IPO
Employees
Officers
The intrinsic value of one UG stock under the Base Case scenario is 7.578 USD.
Compared to the current market price of 7.755 USD, United-Guardian Inc is Overvalued by 2%.